Search results
Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors
Guru Focus· 19 hours agoLong-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, ...
Biogen Shares Surge Following Collaboration With Delta Flight Products: What You Need To Know - ...
Benzinga· 16 hours agoBiogen Inc. BIIB shares saw a notable uptick Monday afternoon, after the company revealed a new...
... Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen...
Morningstar· 4 days agoGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors Glancy Prongay ...
European Commission grants marketing approval to Biogen's ALS drug
Reuters via Yahoo News· 5 days agoThe approval is based on a 108-patient trial that showed Qalsody reduced levels of a neurofilament...
Sangamo Therapeutics Inc [SGMO] stock was sold by BIOGEN INC. at the price of US$3.0 million – Knox...
Knox Daily· 1 day agoIn a filing, Sangamo Therapeutics Inc revealed its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26 ’23. In the deal valued at $0.50 per ...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Finance· 4 days agoBiogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been...
Benzinga· 2 days agoBragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Biogen Inc. ("
Small Business - Picayune Item | Picayune Item
The Picayune Item· 16 hours agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...
... ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial...
Benzinga· 2 days agoSAN DIEGO, June 02, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Biogen Inc. (NASDAQ:BIIB) securities between February 3, 2022 and February 13, 2024, both
BIIB (NASDAQ) FRAUD ALERT: Biogen Inc. Investors who Lost Money are Encouraged to Contact BFA Law...
Benzinga· 3 days agoNEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ:BIIB) Securities Class Action Lawsuit. If you